Impact of universal varicella vaccination in Navarre, 2006-2010;Impacto de la vacunación universal frente a la varicela en Navarra, 2006-2010

Anales del Sistema Sanitario de Navarra

Volumn 34, Issue 2, 2011, Pages 193-202

  Garcia Cenoz M ^a   Castilla, J ^a   Irisarri, F ^a   Arriazu, M ^a   Barricarte, A ^a  

^a INSTITUTO DE SALUD PÚBLICA DE NAVARRA   (Spain)

Author keywords

Vaccination; Varicella

Indexed keywords

CHICKENPOX VACCINE;

ADOLESCENT; ADULT; ARTICLE; CHICKENPOX; CHILD; FALLING; GROUPS BY AGE; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; INCIDENCE; INFANT; INFECTION CONTROL; MAJOR CLINICAL STUDY; PRESCHOOL CHILD; SCHOOL CHILD; SPAIN; VACCINATION;

EID: 84855992625     PISSN: 11376627     EISSN: None     Source Type: Journal    
DOI: 10.4321/S1137-66272011000200006     Document Type: Article

References (17)

1. Seward JF, Watson BM, Peterson CL, Mascola L, Pelosi JW, Zhang JX et al. Varicella disease after introduction of varicella vaccine in the United States, 1995-2000. JAMA 2002; 287: 606-611.
2. Grose C. Varicella vaccination of children in the United States: Assessment after the first decade 1995-2005. J Clin Virol 2005; 33: 89-95.
3. Seward JF, Marin M, Vazquez M. Varicella vaccine effectiveness in the US vaccination program: A review. J Infect Dis 2008; 197: S82-S9.
4. Macartney KK, Beutels P, McIntyre P, Burgess MA. Varicella vaccination in Australia. J Paediatr Child Health 2005; 41: 544-552.
5. Carville KS, Riddell MA, Kelly HA. A decline in varicella but an uncertain impact on zoster following varicella vaccination in Victoria, Australia. Vaccine 2010; 28: 2532-2538.
6. Boot HJ, de Melker HE, Stolk EA, de Wit GA, Kimman TG. Assessing the introduction of universal varicella vaccination in the Netherlands. Vaccine 2006; 24: 6288-6299.
7. Boletín Oficial de Navarra. Orden Foral 133/2006, de 13 de diciembre, de la Consejería de Salud, por la que se modifica en Calendario Oficial de Vacunaciones de Navarra. BON núm 4, 08/01/2007. Boletín Oficial de Navarra 2007.
8. Agencia española de medicamentos y productos sanitarios. Ficha técnica de Varivax ®, revisión 2008. Available from: https://sinaem4.agemed.es/consaem/especialidad.do?metodo=verFichaWordPdf&codigo=65709&formato=pdf&formulario=FICHAS
9. Fox J, Elveback L, Scott W, Gatewood L, Ackerman E. Herd immunity: basic concept end relevance to public health immunization practices. Am J Epidemiol 1971; 94: 179-189.
10. Fox J. Herd immunity and measles. Rev Infect Dis 1983; 5: 463-464.
11. Boletín Oficial de Navarra. Orden Foral 19/2008, de 15 de febrero, de la Consejería de Salud, por la que se modifican las enfermedades incluidas en el Sistema de Vigilancia Epidemiológica de Navarra. BON núm 28, 01/03/2008. 2008.
12. García Cenoz M, Castilla J, Montes Y, Moran J, Salaberri A, Elia F et al. Varicella and herpes zoster incidence prior to the introduction of systematic child vaccination in Navarre, 2005-2006. An Sist Sanit Navar 2008; 31: 71-80.
13. Kwong JC, Tanuseputro P, Zagorski B, Moineddin R, Chan KJ. Impact of varicella vaccination on health care outcomes in Ontario, Canada: Effect of a publicly funded program? Vaccine 2008; 26: 6006-6012.
14. Siedler A, Arndt U. Impact of the routine varicella vaccination programme on varicella epidemiology in Germany. Euro Surveill 2010; 15 (13):pii=19530.
15. Mullooly JP, Maher JE, Drew L, Schuler R, Hu W. Evaluation of the impact of an HMO's varicella vaccination program on incidence of varicella. Vaccine 2004; 22: 1480-1485.
16. Kupek E, Tritany EF. Impact of vaccination against varicella on the reduction of the disease incidence in children and adolescents from Florianopolis, Brazil. J Pediatr (Rio J) 2009; 85: 365-368.
17. Davis MM, Patel MS, Gebremariam A. Decline in varicella-related hospitalizations and expenditures for children and adults after introduction of varicella vaccine in the United States. Pediatrics 2004; 114: 786-792.